Healthcare

Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach

MEDIA RELEASE Investment marks latest step in strategic plan to capture significant part of unprecedented biosimilar patent-expiry market opportunity of...

Bluesight’s Annual Diversion Trends Report Highlights Important Role of Software and Staff Supervision in Controlled Substance Monitoring

2025 Diversion Trends Report provides analysis surrounding controlled substance transactions nationwide, reduced hospital variances, and improved investigations. ALEXANDRIA, Va., June...

error: Content is protected !!